Targeting Mitochondria 2020 will be a Virtual and In-Person Congress


We have been closely following updates and evolving guidance from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come. Today, we have made the decision to combine the In-Person and Virtual conference.


If you cannot attend in-person or virtual due to the restriction and time zone difference, you can access on-demand videos to this entire event, including synced audio/video and slides.

All posters will be in PDF format. You can visit them, upload and interact directly with the poster presenter. You can also exchange with speakers via direct or private exchange during the conference.


We will keep you informed of any new decision.

World Mitochondria Society awarded Minovia during Targeting Mitochondria 2019

The Scientific Committee of Targeting Mitochondria 2019 is honored to discern the Innovation Award to Minovia for their clinical study on the Mitochondria Augmentation Therapy.




The study performed by Minovia and presented during Targeting Mitochondria 2019 "Mitochondria augmentation therapy (MAT): mitochondrial enrichment of hematopoietic stem cells in patients with mitochondrial disease", suggest that MAT can diminish disease progression in patients with mtDNA disorders.

 Mitochondria 2019-D2 356

Mitochondria 2019-D2 329

Mitochondria 2019-D2 335

For media information
Media center: World Mitochondria Society